We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.21B
AUM Growth
-$1.88M
Cap. Flow
-$98.4M
Cap. Flow %
-8.16%
Top 10 Hldgs %
29.75%
Holding
126
New
13
Increased
20
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$17.9M
2
VLO icon
Valero Energy
VLO
+$16.7M
3
ADI icon
Analog Devices
ADI
+$16.4M
4
MRK icon
Merck
MRK
+$16M
5
CVX icon
Chevron
CVX
+$15.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$25.9M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$18.1M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$15.9M
4
DHR icon
Danaher
DHR
+$15.6M
5
HCA icon
HCA Healthcare
HCA
+$15.5M

Sector Composition

Rank Sector Weight
1 Financials 19.47%
2 Technology 14.69%
3 Healthcare 11.02%
4 Industrials 9.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FITB
51
Fifth Third Bancorp
FITB
$52B
$10.9M 0.9%
+243,600
New +$10.7M
PG icon
52
Procter & Gamble
PG
$343B
$10.7M 0.89%
69,900
-62,500
-47% -$9.76M
COST icon
53
Costco
COST
$415B
$10.7M 0.89%
11,600
-5,100
-31% -$4.89M
LEN icon
54
Lennar Class A
LEN
$20.4B
$10.4M 0.87%
+82,900
New +$10.3M
GILD icon
55
Gilead Sciences
GILD
$161B
$10.1M 0.84%
91,280
+22,900
+33% +$2.6M
CMI icon
56
Cummins
CMI
$91.7B
$9.76M 0.81%
+23,100
New +$8.86M
TXN icon
57
Texas Instruments
TXN
$255B
$9.02M 0.75%
49,100
+46,800
+2,035% +$9.15M
BKNG icon
58
Booking.com
BKNG
$138B
$8.64M 0.72%
40,000
– –
TMUS icon
59
T-Mobile US
TMUS
$193B
$8.52M 0.71%
35,600
-12,500
-26% -$3.03M
NDAQ icon
60
Nasdaq
NDAQ
$51.5B
$8.13M 0.67%
91,900
-39,100
-30% -$3.62M
MET icon
61
MetLife
MET
$61B
$8.09M 0.67%
98,200
-74,200
-43% -$5.84M
KIM icon
62
Kimco Realty
KIM
$17.6B
$7.96M 0.66%
+364,400
New +$7.92M
NLY icon
63
Annaly Capital Management
NLY
$16.9B
$7.91M 0.66%
+391,300
New +$8.12M
SPGI icon
64
S&P Global
SPGI
$126B
$7.64M 0.63%
15,700
-18,100
-54% -$9.69M
NVDA icon
65
NVIDIA
NVDA
$5.01T
$6.25M 0.52%
33,500
-2,500
-7% -$436K
CTRA
66
DELISTED
Coterra Energy
CTRA
$5.01M 0.42%
+212,000
New +$5.11M
AAPL icon
67
Apple
AAPL
$4.89T
$4.79M 0.4%
18,800
-5,000
-21% -$1.13M
AGG icon
68
iShares Core US Aggregate Bond ETF
AGG
$138B
$3.46M 0.29%
+34,542
New +$3.43M
NFLX icon
69
Netflix
NFLX
$292B
$2.53M 0.21%
21,100
-13,000
-38% -$1.59M
LLY icon
70
Eli Lilly
LLY
$1.07T
$2.38M 0.2%
3,120
-12,600
-80% -$9.38M
SUSB icon
71
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.29B
$2.24M 0.19%
88,579
– –
WMB icon
72
Williams Companies
WMB
$90.5B
$2.04M 0.17%
32,160
-180,600
-85% -$10.6M
AMP icon
73
Ameriprise Financial
AMP
$46.8B
$1.52M 0.13%
3,100
-27,100
-90% -$13.9M
KO icon
74
Coca-Cola
KO
$354B
$1.48M 0.12%
22,310
-142,000
-86% -$9.77M
AJG icon
75
Arthur J. Gallagher & Co
AJG
$63.7B
$1.08M 0.09%
3,500
-60,200
-95% -$18.1M
1 2
3
4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2025 Portfolio in Review

As of Q3 2025, Payden & Rygel held 126 positions worth $1.21B, down 0.16% from $1.21B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Payden & Rygel withdrew a net $98.4M in Q3 2025, closing 13 positions and reducing 44 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Payden & Rygel opened a new position in CVS Health worth $19.7M.

  • Payden & Rygel's largest Q3 2025 buy was CVS Health: 261,500 shares worth $19.7M.
  • Payden & Rygel added most to Merck in Q3 2025, an estimated $16M increase.
  • Payden & Rygel's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $25.9M.
  • Payden & Rygel fully exited Berkshire Hathaway Class B in Q3 2025, selling an estimated $15.9M.
  • Payden & Rygel's ten largest holdings make up 30% of its $1.21B portfolio in Q3 2025.
  • Payden & Rygel opened 13 new positions and closed 13 in Q3 2025.
  • Payden & Rygel's portfolio value fell 0.16% quarter-over-quarter to $1.21B.

Based on Payden & Rygel's 13F filing for Q3 2025, filed 10 Nov 2025.